Welcome to the e-CCO Library!

P281: Conversion of the ileal pouch-anal anastomosis to a continent ileostomy – outcome and patient satisfaction
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Hermanson, M.(1)*;Bengtson, J.(1);Block, M.(1);
Created: Friday, 14 July 2023, 11:05 AM
P281: Endoscopic healing assessed by advanced optical enhancement techniques combined with faecal calprotectin (FCP) can accurately assess histological healing in ulcerative colitis patients
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

R. Cannatelli*1, U. N. Shivaji2,3, S. C. Smith1, D. Zardo4, A. Bazarova1, G. Gkoutos1, S. Ghosh1,2,3, M. Iacucci1,2,3,5

Created: Friday, 22 February 2019, 9:41 AM
P281: Evaluation of trough level and disease activity after switch from adalimumab originator to biosimilar in patients with Inflammatory Bowel Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Deprez, N.(1);De Somer, T.(2);Baert, D.(2);Deceuninck, M.(3);Huys, I.(2);Mattens, V.(4);Sterckx, A.(4);Vanden Branden, S.(4);Vanderstraeten, E.(2);Vandervoort, J.(4);Vanheddegem, N.(2);Dewint, P.(2);
Created: Wednesday, 2 June 2021, 4:12 PM
P281: Factors at diagnosis associated with disabling disease course in Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Ponte A., Pinho R., Rodrigues A., Silva J., Rodrigues J., Sousa M., Silva A.P., Alberto L., Carvalho J.

Created: Wednesday, 20 February 2019, 10:36 AM
P281: One simple question is sufficient for measuring medication adherence in inflammatory bowel disease patients using self-report
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Severs*1, M.-J. Mangen2, H. H. Fidder1, M. E. van der Valk1, M. van der Have1, A. A. van Bodegraven3, 4, C. H. M. Clemens5, G. Dijkstra6, J. M. Jansen7, D. J. de Jong8, N. Mahmmod9, P. C. van de Meeberg10, A. E. van der Meulen- de Jong11, M. Pierik12, C. Y. Ponsioen13, M. J. L. Romberg- Camps3, P. D. Siersema1, J. R. Vermeijden14, J. van der Woude15, P. N. Zuithoff16, B. Oldenburg1

Created: Friday, 22 February 2019, 9:49 AM
P281: TELEIBD: A telematic fast-track pathway for patients with high suspicion of Inflammatory Bowel Disease in primary care.
Year: 2022
Source: ECCO'22
Authors: Pradera Cibreiro, C.(1);Ramos Alonso, M.(1);Fernández López, M.(1);Molina Arriero, G.(1);Fraga Iriso, R.(1);González Furelos, T.(1);Ollero Pena, V.(1);Echarri Piudo, A.(1);
Created: Friday, 11 February 2022, 3:52 PM
P282 Early disease acceleration in patients with newly diagnosed Crohn’s disease in India and Israel: Insights from an East-West inception cohort
Year: 2020
Source:

ECCO'20 Vienna

Authors:

I. Goren1, H. Yanai1, P. Pal2, B. Adigopula2, S. Pendyala2, G. Ganesh2, K. Yadgar1, R. Banerjee2, I. Dotan1, The Indo-Israeli IBD GastroEnterology paRtnership, ‘TiiiGER’ project

Created: Thursday, 30 January 2020, 10:12 AM
P282: Combination of biomarkers reflecting type IV collagen degradation and citrullinated vimentin predicts response to adalimumab with high diagnostic accuracy, in patients with Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. H. Mortensen*1, M. A. Karsdal1, H. Grønbæk2, C. L. Hvas2, A. Dige2, T. Manon-Jensen1

Created: Friday, 22 February 2019, 9:41 AM
P282: Despite surveillance and increased use of biologics and immunosuppressives colorectal cancer detection in IBD patients remains unchanged over the past ten years
Year: 2018
Source: ECCO '18 Vienna
Authors:

U.N. Shivaji1*, S.C.L. Smith1,2, R. Hejmadi3, T. Iqbal1, N. Bhala1, R. Cooney1, S. Ghosh1,2, M. Iacucci1,2

Created: Thursday, 21 February 2019, 9:14 AM
P282: Does colonoscopy alter the post-procedural fecal calprotectin results in Crohn's disease patients with ileocecal resection?
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Erzin Y., Demir N., Bozcan S., Yıldırım S., Hatemi I., Celik A.F.

Created: Wednesday, 20 February 2019, 10:36 AM
P282: High plasma oncostatin-M predicts non-response to tumour necrosis factor-alpha antagonists in inflammatory bowel disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Guo, A.(1);Ross, C.(2);Chande, N.(3);Gregor, J.(3);Ponich, T.(3);Beaton, M.(3);Khanna, R.(3);Kim, R.(4);Wilson, A.(5);
Created: Wednesday, 2 June 2021, 4:12 PM
P282: Influence of phenotype at diagnosis and of other potential prognostic factors on the prognosis of Crohn’s Disease in Chinese population
Year: 2022
Source: ECCO'22
Authors: Xiao, Z.(1,2);Wu, L.(1);Cao, Q.(1);
Created: Friday, 11 February 2022, 3:52 PM
P282: Isolated colonic Crohn's disease and extensive ulcerative colitis: is there a reel difference?
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Ben Safta, N.(1)*;Ben Mustpha, N.(1);Khemiri, W.(1);Serghini, M.(1);Laabidi, S.(1);Fekih, M.(1);Labidi, A.(1);Boubaker, J.(1);
Created: Friday, 14 July 2023, 11:05 AM
P282: The long-term effect of biologics in newborns
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

B. Truta*, J. Canner, J. Efron, B. Safar

Created: Friday, 22 February 2019, 9:49 AM
P283 Patient-reported symptoms over a period of 14 days reliably predict endoscopic and histological disease activity in ulcerative colitis (UC)
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Kormilitzin1, A.J. Walsh2, L. Matini2, R. Kantschuster2, M. Lepetyukh3, J. Wilson2, O. Brain2, R. Palmer2, T. Ambrose2, J. Satsangi2, S.P.L. Travis2

Created: Thursday, 30 January 2020, 10:12 AM
P283: Awareness and perceptions of colorectal cancer risk and screening in Inflammatory Bowel Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Liu, E.(1)*;Erande, A.(2);McLaughlin, J.(3);Limdi, J.K.(1);
Created: Friday, 14 July 2023, 11:05 AM
P283: Bowel urgency in patients with moderate to severe ulcerative colitis: prevalence and correlation with clinical outcomes, biomarker levels, and health-related quality of life from U-ACHIEVE, a Phase 2b study of upadacitinib
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Ghosh*1, E. Louis2, E. V. Loftus Jr3, W. Reinisch4, F. Cataldi5, W. Zhou5, W-J. Lee5, J. Panes6

Created: Friday, 22 February 2019, 9:41 AM
P283: Decrease in bowel wall thickness at intestinal ultrasound accurately detects early endoscopic remission and improvement in ulcerative colitis patients on tofacitinib: a longitudinal prospective cohort study.
Year: 2021
Source: ECCO'21 Virtual
Authors: de Voogd, F.(1);Van Wassenaer, E.(2);Mookhoek, A.(3);Bots, S.(1);Van Gennep, S.(1);Duijvestein, M.(1);Ponsioen, C.(1);Löwenberg, M.(1);D'Haens, G.(1);Gecse, K.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P283: Development, validation and clinical application of a novel tool to measure disease-related knowledge in patients with inflammatory bowel disease: IBD-KNOW
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

H. Yoon*1, S.-K. Yang2, H. So2, K. E. Lee3, S. H. Park2, S.-A. Jung3, C. M. Shin1, Y. S. Park1, N. Kim1, D. H. Lee1

Created: Friday, 22 February 2019, 9:49 AM
P283: Infliximab re-challenge: could it be an option in refractory IBD patients?
Year: 2022
Source: ECCO'22
Authors: Truyens, M.(1);Pijoan Comas, E.(2);Glorieus, E.(1);Geldof, J.(1);Lobatón Ortega, T.(1);
Created: Friday, 11 February 2022, 3:52 PM